chronic
rhinosinus
cr
complex
diseas
character
inflamm
paranas
sinus
sinonas
mucosa
persist
sinonas
symptom
last
least
week
object
find
sinonas
inflamm
via
nasal
endoscopi
comput
tomographi
paranas
sinus
recommend
diagnosi
cr
clinic
research
purpos
diagnosi
base
symptom
may
accur
pathogenesi
cr
multifactori
infecti
genet
environment
factor
play
role
diseas
process
yet
exact
contribut
factor
unclear
infect
associ
cr
typic
viral
bacteri
case
may
fungal
cr
exacerb
trigger
infecti
pathogen
refer
infecti
cr
review
term
well
defin
literatur
role
bacteri
infect
cr
unknown
viral
infect
cr
well
studi
virus
may
associ
acut
rhinosinus
review
elabor
infecti
cr
specif
focus
bacteri
infect
underli
reason
infect
associ
comorbid
form
cr
discuss
elsewher
journal
cr
affect
million
peopl
popul
unit
state
alon
cr
without
nasal
polyp
crssnp
cr
nasal
polyp
crswnp
account
approxim
cr
case
respect
chronic
diseas
result
reduc
qualiti
life
caus
poor
sleep
fatigu
bodili
pain
cr
associ
signific
health
care
cost
base
systemat
review
lead
annual
expenditur
us
dollar
equival
billion
direct
cost
billion
indirect
cost
surveybas
studi
identifi
period
close
million
outpati
visit
unit
state
cr
antibiot
prescrib
time
suspect
great
major
clinic
visit
infecti
cr
exacerb
suggest
signific
util
health
care
resourc
difficulttotreat
cr
recurr
acut
rhinosinus
rar
may
associ
humor
immunodefici
discuss
later
small
percentag
patient
refractori
sinus
genet
disord
cystic
fibrosi
cf
primari
ciliari
dyskinesia
pcd
increas
risk
develop
diseas
patient
crssnp
gener
present
symptom
facial
pain
purul
drainag
wherea
crswnp
may
similar
symptom
predominantli
complain
nasal
obstruct
without
hyposmia
anosmia
patient
cr
degre
persist
sinonas
symptom
wherea
patient
rar
symptom
free
episod
acut
exacerb
patient
complain
constant
nasal
congest
thick
peanut
butterlik
secret
nasal
sinu
caviti
evalu
allerg
fungal
rhinosinus
abbrevi
use
cfcystic
fibrosi
cftrcystic
fibrosi
transmembran
conduct
regul
crschronic
rhinosinus
crssnpchronic
rhinosinus
without
nasal
polyp
crswnpchronic
rhinosinus
nasal
polyp
cvidcommon
variabl
immunodefici
nthinontyp
haemophilu
influenza
pcdprimari
ciliari
dyskinesia
rarsrecurr
acut
rhinosinus
sadspecif
antibodi
defici
snpsingl
nucleotid
polymorph
transduc
activ
transcript
urtiupp
respiratori
tract
infect
allerg
rhiniti
asthma
bronchiectasi
immunodefici
cf
pcd
autoimmun
diseas
eosinophil
granulomatosi
polyangi
associ
cr
causal
develop
cr
proven
comorbid
coexist
medic
condit
either
predispos
patient
cr
develop
infecti
exacerb
consequenti
outcom
chronic
sinonas
condit
asthma
cr
often
coexist
asthma
exacerb
associ
cr
exacerb
treatment
cr
result
improv
asthma
control
larg
percentag
patient
bronchiectasi
cr
presenc
cr
associ
sever
bronchiectasi
disord
mucociliari
transport
system
may
contribut
develop
cr
well
cf
caus
defect
cystic
fibrosi
transmembran
conduct
regul
cftr
gene
specif
mutat
found
patient
pcd
cf
pcd
discuss
section
journal
issu
exact
pathogenesi
cr
remain
unknown
pathophysiolog
cr
complex
base
fundament
principl
dysfunct
interact
host
environment
factor
interfac
sinonas
mucosa
result
multipl
differ
mechan
propos
staphylococcu
aureu
aureu
implic
pathogenesi
nasal
polyp
local
system
ige
aureu
enterotoxin
demonstr
patient
crswnp
level
specif
ige
directli
correl
type
eosinophil
inflamm
characterist
crswnp
concept
discuss
part
journal
seri
role
bacteria
cr
unclear
sinu
caviti
steril
zone
colon
variou
speci
bacteria
polymicrobi
bacteri
speci
identifi
healthi
diseas
sinu
mucosa
convent
cultur
molecular
techniqu
propos
colon
bacteria
contribut
pathogenesi
cr
via
format
biofilm
biofilm
compos
layer
live
bacteria
within
matrix
protein
nucleic
acid
bacteri
plaqu
mucos
surfac
allow
infecti
pathogen
develop
antimicrobi
resist
evad
host
defens
bacteria
metabol
inact
potenti
lead
infecti
cr
exacerb
studi
suggest
bacteri
biofilm
caus
recalcitr
cr
alter
sinonas
microbiom
may
also
contribut
pathogenesi
cr
patient
cr
microbiom
dysbiosi
character
reduc
bacteri
divers
increas
rel
abund
specif
bacteri
speci
compar
healthi
individu
alter
microbi
flora
contribut
phenotyp
differ
patient
cr
without
cr
immun
barrier
hypothesi
caus
cr
also
propos
epitheli
cell
secret
host
defens
molecul
includ
small
peptid
enzym
small
peptid
defensin
cathelicidin
larg
enzymat
protein
lysozym
lactoferrin
kill
bacteria
abnorm
epitheli
cell
barrier
function
result
impair
immun
system
allow
colon
infecti
pathogen
bacteria
fungi
famili
protein
produc
epitheli
cell
play
import
role
cell
differenti
barrier
function
antimicrobi
activ
studi
patient
cr
shown
reduc
level
protein
psoriasin
calprotectin
may
potenti
increas
suscept
infect
anoth
famili
epitheliumsecret
protein
call
plunc
palat
lung
nasal
epithelium
clone
involv
innat
immun
profoundli
reduc
polyp
tissu
patient
crswnp
addit
abnorm
innat
immun
system
may
contribut
infecti
cr
includ
reduc
express
gene
respons
express
epitheli
protein
decreas
cr
import
epitheli
barrier
function
epitheli
cell
host
defens
molecul
releas
regul
signal
transduc
activ
transcript
blunt
signal
demonstr
cr
may
respons
decreas
antimicrobi
protein
releas
epitheli
cell
nasal
polyp
noteworthi
innat
immun
receptor
may
play
role
cr
pathogenesi
bitter
tast
receptor
activ
bacteri
product
stimul
epitheli
cell
produc
nitrou
oxid
help
kill
bacteria
assist
mucociliari
clearanc
pathogen
prevent
upper
respiratori
tract
infect
urti
gene
polymorph
genotyp
make
bitter
tast
receptor
inact
predispos
patient
gramneg
urti
risk
factor
develop
cr
defect
epitheli
cell
barrier
function
creat
impair
innat
immun
system
may
make
sinonas
mucosa
vulner
pathogen
microbi
colon
overal
singl
caus
multipl
factor
make
host
suscept
cr
although
patient
cr
ongo
sinonas
symptom
may
develop
episod
worsen
symptom
may
character
purul
nasal
discharg
aerob
anaerob
bacteri
speci
obtain
diseas
nondiseas
sinu
mucosa
suffer
cr
overal
aureu
common
organ
isol
patient
cr
base
molecular
diagnost
aureu
staphylococcu
epidermidi
propionibacterium
acn
abund
organ
patient
cr
gener
fewer
bacteri
pathogen
identifi
sinu
mucosa
via
convent
cultur
compar
molecularbas
techniqu
asid
aureu
pathogen
cultur
patient
cr
includ
coagulas
neg
staphylococcu
haemophilu
influenza
h
influenza
streptococcu
pneumonia
addit
patient
cr
purul
secret
increas
abund
prevotella
streptococcu
veillonella
speci
identifi
via
quantit
dna
pcr
contrast
usual
communityacquir
rhinosinus
exacerb
nosocomi
rhinosinus
exacerb
predominantli
caus
gramneg
bacteria
pseudomona
aeruginosa
p
aeruginosa
proteu
mirabili
klebsiella
pneumonia
commonli
isol
organ
patient
cr
summar
tabl
microorgan
detect
either
via
convent
cultur
molecular
diagnost
like
part
resid
microbiom
probabl
help
maintain
healthi
sinu
mucosa
addit
may
nonpathogen
bacteria
within
sinu
mucosa
inde
respons
cr
diseas
process
exact
role
unclear
viral
urti
contribut
cr
exacerb
one
studi
coronaviru
identifi
via
molecular
sequenc
common
viru
patient
cr
although
exact
role
virus
cr
exacerb
certain
like
contribut
disturb
symbiot
microbiom
lead
clinic
diseas
patient
difficulttotreat
cr
evalu
underli
immunodefici
antibodi
defici
common
primari
immunodefici
associ
cr
recent
metaanalysi
antibodi
defici
patient
cr
report
combin
preval
igg
iga
igm
defici
patient
recurr
cr
patient
difficulttotreat
cr
antibodi
defici
occur
defect
antibodi
product
common
variabl
immunodefici
iga
igm
defici
poor
antibodi
function
specif
antibodi
defici
common
variabl
immunodefici
cvid
common
symptomat
antibodi
defici
character
reduct
igg
level
standard
deviat
associ
low
iga
andor
igm
level
addit
impair
respons
polysaccharid
protein
antigen
cvid
patient
cvid
cr
preval
select
iga
defici
iga
level
mgdl
estim
peopl
iga
defici
patient
asymptomat
howev
approxim
patient
cr
may
iga
defici
specif
antibodi
defici
sad
defin
impair
respons
immun
polysaccharid
antigen
pneumovax
set
normal
quantit
immunoglobulin
level
igg
iga
igm
histori
recurr
prolong
sinopulmonari
infect
adequ
respons
polysaccharid
vaccin
well
defin
howev
pneumococc
serotyp
mcgml
vaccin
retrospect
review
patient
difficulttotreat
cr
patient
note
sad
humor
immunodefici
typic
associ
infecti
cr
summar
tabl
ii
patient
cr
immun
dysfunct
may
requir
aggress
treatment
strategi
includ
prophylact
antibiot
prevent
recurr
infecti
cr
exacerb
earli
culturebas
antibiot
therapi
immunoglobulin
ig
replac
therapi
earli
surgic
manag
odontogen
rhinosinus
suspect
patient
dental
pain
patient
recent
dental
oral
surgic
procedur
dental
infect
caus
odontogen
rhinosinus
specif
involv
maxillari
sinus
typic
unilater
maxillari
sinus
case
believ
due
odontogen
infect
odontogen
rhinosinus
occur
schneiderian
membran
membran
line
maxillari
sinu
mucosa
breach
dental
infect
dental
procedur
bacteri
organ
commonli
found
oral
flora
typic
caus
odontogen
rhinosinus
includ
aerob
anaerob
speci
treatment
odontogen
rhinosinus
import
untreat
infect
extend
orbit
cranial
structur
caus
seriou
complic
furthermor
underli
odontogen
infect
address
either
via
endodont
therapi
root
canal
remov
infect
sourc
prevent
recurr
odontogen
rhinosinusit
treatment
treatment
option
cr
includ
topic
intranas
steroid
oral
antibiot
topic
antibiot
nasal
salin
irrig
oral
steroid
combin
oral
antibiot
steroid
difficulttotreat
cr
may
requir
surgeri
cr
set
underli
immunodefici
may
necessit
prophylact
antibiot
ig
replac
therapi
topic
intranas
steroid
help
decreas
sinonas
inflamm
extrem
effect
manag
patient
cr
nasal
salin
irrig
remov
mucu
assist
clear
bacteri
biofilm
combin
topic
intranas
steroid
nasal
salin
irrig
may
help
cr
among
treatment
option
topic
intranas
steroid
superior
singl
therapi
alon
although
treatment
oral
antibiot
usual
first
therapeut
option
util
cr
strong
evid
use
oral
antibiot
cr
lack
literatur
placebocontrol
studi
evalu
treatment
oral
antibiot
cr
cochran
review
system
antibiot
cr
includ
random
studi
show
limit
effect
macrolid
therapi
sinc
one
studi
show
longterm
use
azithromycin
treatment
cr
show
benefit
compar
placebo
anoth
studi
evalu
use
oral
antibiot
patient
crswnp
discuss
section
journal
oral
antibiot
may
use
infecti
cr
exacerb
especi
patient
purul
drainag
topic
antibiot
may
effect
cr
like
benefit
postesinu
surgeri
patient
patient
receiv
culturedirect
antibiot
final
oral
steroid
provid
symptomat
relief
nasal
congest
improv
sens
smell
patient
crswnp
retrospect
studi
look
oral
antibiot
steroid
togeth
patient
cr
demonstr
improv
symptom
decreas
radiograph
sever
sinu
diseas
decreas
likelihood
sinu
surgeri
although
avail
therapi
cr
better
reliabl
target
treatment
option
necessari
high
preval
cr
inherit
syndrom
cf
pcd
ataxia
telangiectasia
young
syndrom
suggest
genet
like
play
role
develop
cr
genet
associ
studi
help
identifi
numer
singl
nucleotid
polymorph
snp
gene
involv
innat
ie
tolllik
receptor
pathway
adapt
immun
arachidon
acid
metabol
sinonas
tissu
remodel
howev
mani
genet
studi
find
limit
lack
reproduc
result
conflict
data
largescal
genomewid
associ
studi
replic
discov
genet
data
need
valid
associ
genespecif
snp
identifi
patient
cr
date
associ
cr
cftr
gene
mutat
promis
find
due
replic
data
variou
studi
high
preval
cr
patient
cf
suggest
cftr
gene
may
involv
pathogenesi
cr
biomark
diagnosi
infecti
cr
exacerb
current
lack
biomark
consist
use
identifi
acut
cr
exacerb
although
direct
sinu
caviti
cultur
result
use
clinic
practic
manag
cr
alway
reliabl
due
high
rate
bacteri
colon
sinu
mucosa
studi
chinchilla
infect
nontyp
h
influenza
nthi
strain
nthi
protein
discov
sinonas
secret
show
promis
potenti
biomark
activ
diseas
largescal
human
studi
requir
valid
type
biomark
approach
establish
identifi
patient
infecti
cr
patient
recurr
infecti
cr
exacerb
difficulttotreat
cr
fail
empir
treatment
combin
topic
oral
antibiot
without
steroid
undergo
nasal
endoscopi
get
culturedirect
antibiot
therapi
indic
best
diagnost
approach
avail
current
import
note
culturebas
diagnosi
may
accur
molecular
diagnost
concomit
immunodefici
also
suspect
subset
patient
laboratori
workup
includ
complet
blood
count
differenti
quantit
immunoglobulin
igg
iga
igm
specif
antibodi
respons
polysaccharid
antigen
igg
antibodi
respons
week
postvaccin
pneumococc
polysaccharid
vaccin
complement
function
necessari
measur
band
tcell
number
flow
cytometri
perform
patient
highrisk
sexual
behavior
undergo
hiv
screen
exclud
acquir
immunodefici
prophylact
antibiot
ig
replac
therapi
consid
patient
recurr
exacerb
infecti
cr
proven
defect
humor
immun
patient
cr
concern
immunodefici
presenc
atyp
opportunist
pathogen
sinonas
mucosa
refer
evalu
clinic
special
allergi
sinu
diseas
immunodefici
anatom
abnorm
deviat
nasal
septum
believ
caus
recurr
infecti
cr
exacerb
patient
refer
otolaryngologist
surgic
evalu
addit
patient
diagnos
nasal
polyp
cr
earli
age
p
aeruginosa
cultur
sinonas
caviti
evalu
cf
focus
research
need
identifi
defect
innat
immun
mucociliari
clearanc
impact
sinonas
microbiom
allergi
genet
develop
new
prevent
therapeut
option
manag
cr
exampl
antibiofilmdirect
intervent
could
help
minim
cr
exacerb
target
colon
microbiom
specif
genotyp
direct
toward
bitter
tast
receptor
may
help
identifi
specif
endotyp
cr
effort
need
identifi
true
impact
oral
antibiot
optim
durat
antibiot
use
infecti
cr
although
biomark
cr
develop
larger
scale
studi
need
conduct
human
confirm
valid
diagnost
test
market
clinic
use
overal
given
complex
cr
microbiom
fingerprint
may
next
step
develop
precis
diagnost
approach
diseas
infecti
cr
subtyp
umbrella
cr
infecti
cr
exacerb
trigger
virus
caus
urti
imbal
among
bacteri
speci
make
sinonas
microbiom
signific
discoveri
understand
complex
pathogenesi
cr
ongo
focu
microbiota
within
sinu
caviti
nevertheless
uniqu
biomark
identifi
infecti
cr
exacerb
evidencebas
treatment
option
cr
still
lack
gap
need
investig
